DaVita (GB:0I7E)
LSE:0I7E

DaVita (0I7E) Share Price & Analysis

0 Followers

0I7E Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$66.93 - $116.76
Previous Close$95.68
Volume795.00
Average Volume (3M)335.00
Market Cap
$8.74B
Enterprise ValueN/A
Total Cash (Recent Filing)$339.93M
Total Debt (Recent Filing)$11.48B
Price to Earnings (P/E)19.6
Beta0.64
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.89
Shares Outstanding91,300,000
10 Day Avg. Volume15
30 Day Avg. Volume335
Standard Deviation0.10
R-Squared0.25
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.43
Price to Sales (P/S)3.57
Price to Cash Flow (P/CF)5.00
P/FCF Ratio6.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
Price Target Upside28.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3


Financials

Annual

0I7E FAQ

What was DaVita’s price range in the past 12 months?
DaVita lowest share price was $66.93 and its highest was $116.76 in the past 12 months.
    What is DaVita’s market cap?
    Currently, no data Available
    When is DaVita’s upcoming earnings report date?
    DaVita’s upcoming earnings report date is Nov 08, 2023 which is in 41 days.
      How were DaVita’s earnings last quarter?
      DaVita released its earnings results on Aug 03, 2023. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.707 by $0.373.
        Is DaVita overvalued?
        According to Wall Street analysts DaVita’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does DaVita pay dividends?
          DaVita does not currently pay dividends.
          What is DaVita’s EPS estimate?
          DaVita’s EPS estimate is $2.01.
            How many shares outstanding does DaVita have?
            DaVita has 91,300,000 shares outstanding.
              What happened to DaVita’s price movement after its last earnings report?
              DaVita reported an EPS of $2.08 in its last earnings report, beating expectations of $1.707. Following the earnings report the stock price went up 5.975%.
                Which hedge fund is a major shareholder of DaVita?
                Among the largest hedge funds holding DaVita’s share is Berkshire Hathaway Inc. It holds DaVita’s shares valued at 4B.

                  ---

                  DaVita Stock Smart Score

                  The DaVita Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  DaVita

                  DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  DaVita
                  UnitedHealth
                  Humana
                  Cigna
                  Centene

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis